跳至主要内容
临床试验/NCT03007290
NCT03007290已完成不适用

Clinical Usefulness of Therapeutic Drug Monitoring of Colistin in Patients Treated With Colistin.

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2016年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
AKI

研究概览

简要总结

Clinical usefulness of therapeutic drug monitoring of colistin in patients treated with colistin

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age over 18 years old.
  • Those who receive colistin therapy for the treatment of multi-drug resistant gram negative bacteria infection.

排除标准

  • Those who received colistin therapy less than 48 hours
  • Those who received colistin therapy through the bronchus

研究组 & 干预措施

Treatment group

Experimental

Group with therapeutic drug monitoring

干预措施: Therapeutic drug monitoring (Other)

结局指标

主要结局

AKI

时间窗: Through study completion, an average of 1 month

Emergence rate of acute kidney injury

次要结局

  • Death(Through study completion, an average of 1 month)
  • Negative conversion rate(Through study completion, an average of 1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eu Suk Kim

Professor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验